Funding for this research was provided by:
Universität Duisburg-Essen
Universitätsklinikum Essen
Article History
Received: 10 May 2024
Accepted: 6 June 2024
First Online: 11 June 2024
Declarations
:
: Tim J von Oertzen has received payment or honoraria for lectures, presentations, or manuscript writing support from Angelini Pharma, Eisai, GW Pharmaceuticals, Jazz Pharma, Livanova, and UCB Pharma and has served on advisory boards for Angelini Pharma, Arvelle Therapeutics, GW Pharmaceuticals, Jazz Pharma, and Zogenix Pharma outside the submitted work. Judith Wagner has received payment or honoraria for lectures, presentations, or travel grants from Boehringer Ingelheim, Janssen-Cilag GmbH, Pfizer Pharma GmbH, Novartis Pharma GmbH, Roche Austria GmbH, and UCB Pharma AG and has served on advisory boards for Janssen-Cilag GmbH and Novartis Pharma GmbH outside the submitted work. Eva Soellradl reports no conflicts of interest.Research involving human participants and informed consent.This research involves a retrospective analysis of patient data. It was approved by the Ethics Committee of Upper Austria. Informed consent was waived due to the retrospective character.